Results
|
11181.
|
|
|
11182.
|
|
|
11183.
|
|
|
11184.
|
|
|
11185.
|
|
|
11186.
|
|
|
11187.
|
|
|
11188.
|
|
|
11189.
|
|
|
11190.
|
|
|
11191.
|
|
|
11192.
|
|
|
11193.
|
|
|
11194.
|
Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study. Austrian Biological Response Modifier (BRM) Study Group. [electronic resource] by
- Thaler, J
- Gastl, G
- Fluckinger, T
- Niederwieser, D
- Huber, H
- Seewann, H
- Sill, H
- Lang, A
- Falk, M
- Duba, C
- Utermann, G
- Kühr, T
- Aulitzky, W
- Huber, C
Producer: 19961126
In:
Annals of hematology vol. 72
Availability: No items available.
|
|
11195.
|
|
|
11196.
|
|
|
11197.
|
|
|
11198.
|
|
|
11199.
|
|
|
11200.
|
|